Carlos Loya
Scientist | Biotech Builder | Venture Partner
- Role
- Venture Partner at 82vs
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
About Carlos Loya
Scientist and biotech executive with a track record of building innovative companies and teams that deliver meaningful medicines. As a Founding team member of SAGE Therapeutics and Praxis Precision Medicines (NASDAQ: PRAX), shaped strategy, discovery, and development of multiple programs—two of which earned FDA approval: Zulresso™ and Zurzuvae™.Combining deep scientific expertise in neuroscience and RNA biology with proven business strategy, I thrive at the intersection of science and execution. I\'m driven by the mission of bringing breakthrough therapeutics to patients while creating sustainable value.Core competencies: Neuroscience | Psychiatry | Neurology | Ophthalmology | Corporate Development | Licensing & Partnerships | IPO & Capital Raising | RNAi & microRNA Biology | Drug Discovery Strategy | Commercial & Clinical Development
Experience
Venture Partner
Jan 2024 — Present · Boston, MA, US
Education
Harvard Medical School
PhD, Neurobiology
University of Lausanne - UNIL
BS, Biochemistry and French
New Mexico State University
BS, Biochemistry
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.